Cymbalta litigation
Claims allege that stopping Cymbalta produces a withdrawal syndrome far more common and more severe than its label disclosed.
Free case review
What the claims allege
The Cymbalta label long described discontinuation symptoms as occurring at a rate of one percent or greater, while the litigation alleged internal data showed a far higher share of patients experienced withdrawal, including electric-shock sensations, vertigo, and severe mood symptoms when stopping the drug.
Injuries named in the litigation
- Severe withdrawal ("brain zaps")
- Dizziness, nausea, and insomnia
- Anxiety, agitation, and mood disturbance on discontinuation
Who may qualify
If you suffered severe, prolonged withdrawal symptoms after discontinuing Cymbalta (duloxetine), you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.